Efavirenz as a potential drug for the treatment of triple-negative breast cancers

被引：0
|
作者：
P.-T. Chiou
S. Ohms
P. G. Board
J. E. Dahlstrom
D. Rangasamy
M. G. Casarotto
机构：
[1] The Australian National University,ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research
[2] The Australian National University,The John Curtin School of Medical Research
[3] The Australian National University,Anatomical Pathology, ACT Pathology, Canberra Hospital and ANU Medical School, ANU College of Health and Medicine
来源：
Clinical and Translational Oncology | 2021年 / 23卷
关键词：
Triple-negative breast cancer; Efavirenz; LINE-1; Retrotransposon; Fatty acid metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：353 / 363
页数：10
相关论文
共 50 条
  • [41] Recent advances in the treatment of triple-negative breast cancer
    Pogoda, Katarzyna
    Jagiello-Gruszfeld, Agnieszka
    Kunkiel, Michal
    Niwinska, Anna
    Nowecki, Zbigniew
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (06): : 433 - 443
  • [42] Triple-negative breast cancer in the elderly: Prognosis and treatment
    Kaplan, Henry G.
    Malmgren, Judith A.
    Atwood, Mary K.
    BREAST JOURNAL, 2017, 23 (06) : 630 - 637
  • [43] Presentation and treatment of aggressive, Triple-Negative carcinosarcoma of the breast
    Vizgan, Niels
    Jokar, Tahereh Orouji
    Enayati, Ladan
    Salyana, Muhammad
    Gotlieb, Vladimir K.
    CLINICAL CASE REPORTS, 2022, 10 (07):
  • [44] Nanomaterials for the Diagnosis and Treatment of Triple-Negative Breast Cancer
    Sun, Xuan
    Li, Dandan
    Lv, Yue
    Zhang, Mengnan
    Qiao, Dianhe
    Zhang, Zuyuan
    Ren, Han
    Zhang, Ying
    Yang, Zhimou
    Gao, Jie
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2024, 16 (06)
  • [45] Advances in the systemic treatment of triple-negative breast cancer
    Lebert, J. M.
    Lester, R.
    Powell, E.
    Seal, M.
    McCarthy, J.
    CURRENT ONCOLOGY, 2018, 25 : S142 - S150
  • [46] Emerging treatment approaches for triple-negative breast cancer
    Maurizio Capuozzo
    Venere Celotto
    Mariachiara Santorsola
    Antonio Fabozzi
    Loris Landi
    Francesco Ferrara
    Assunta Borzacchiello
    Vincenza Granata
    Francesco Sabbatino
    Giovanni Savarese
    Marco Cascella
    Francesco Perri
    Alessandro Ottaiano
    Medical Oncology, 41
  • [47] Triple-negative breast cancer: treatment challenges and solutions
    Collignon, Joelle
    Lousberg, Laurence
    Schroeder, Helene
    Jerusalem, Guy
    BREAST CANCER-TARGETS AND THERAPY, 2016, 8 : 93 - 107
  • [48] Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
    Deng, Zhou J.
    Morton, Stephen W.
    Ben-Akiva, Elana
    Dreaden, Erik C.
    Shopsowitz, Kevin E.
    Hammond, Paula T.
    ACS NANO, 2013, 7 (11) : 9571 - 9584
  • [49] Emerging treatment approaches for triple-negative breast cancer
    Capuozzo, Maurizio
    Celotto, Venere
    Santorsola, Mariachiara
    Fabozzi, Antonio
    Landi, Loris
    Ferrara, Francesco
    Borzacchiello, Assunta
    Granata, Vincenza
    Sabbatino, Francesco
    Savarese, Giovanni
    Cascella, Marco
    Perri, Francesco
    Ottaiano, Alessandro
    MEDICAL ONCOLOGY, 2023, 41 (01)
  • [50] Atezolizumab in the treatment of metastatic triple-negative breast cancer
    Perez-Garcia, Jose
    Soberino, Jesus
    Racca, Fabricio
    Gion, Maria
    Stradella, Agostina
    Cortes, Javier
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (09) : 981 - 989
12345